INTERVIEW: Prenatal test developer Natera sees wide Panorama
This article was originally published in Clinica
Executive Summary
The dust has settled since Natera, a maker of noninvasive prenatal tests for pregnant women, raised $54.6m in series E financing, the biggest medtech funding round of 2013 at the time (www.clinica.co.uk, 1 May 2013). Since then, this amount has been eclipsed by the $167.7m pulled in by knee implant developer ConforMIS (www.clinica.co.uk, 2 August 2013) – but the excitement over Natera’s Panorama test remains.